Search by Drug Name or NDC
NDC 70515-0700-60 Rilutek 50 mg/1 Details
Rilutek 50 mg/1
Rilutek is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Covis Pharma US, Inc. The primary component is RILUZOLE.
MedlinePlus Drug Summary
Riluzole is used to treat amyotrophic lateral sclerosis (ALS; Lou Gehrig's disease). Riluzole is in a class of medications called benzothiazoles. It works by changing the activity of certain natural substances in the body that affect nerves and muscles.
Related Packages: 70515-0700-60Last Updated: 02/19/2023
MedLinePlus Full Drug Details: Riluzole
Product Information
| NDC | 70515-0700 |
|---|---|
| Product ID | 70515-700_6f43fef8-e4d9-4552-81f5-f6fd7f961de0 |
| Associated GPIs | 74503070000320 |
| GCN Sequence Number | 024508 |
| GCN Sequence Number Description | riluzole TABLET 50 MG ORAL |
| HIC3 | H6I |
| HIC3 Description | AMYOTROPHIC LATERAL SCLEROSIS AGENTS |
| GCN | 12120 |
| HICL Sequence Number | 010247 |
| HICL Sequence Number Description | RILUZOLE |
| Brand/Generic | Brand |
| Proprietary Name | Rilutek |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | riluzole |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 50 |
| Active Ingredient Units | mg/1 |
| Substance Name | RILUZOLE |
| Labeler Name | Covis Pharma US, Inc |
| Pharmaceutical Class | Benzothiazole [EPC], Benzothiazoles [CS] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA020599 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70515-0700-60 (70515070060)
| NDC Package Code | 70515-700-60 |
|---|---|
| Billing NDC | 70515070060 |
| Package | 1 BOTTLE in 1 CARTON (70515-700-60) / 60 TABLET in 1 BOTTLE |
| Marketing Start Date | 2016-08-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |